Access to medication abortion has changed and then changed again over the past week, leaving some doctors and patients confused. But a nonsurgical option that most people in the US use to manage abortions at home is still available – at least for now.

Gov. Maura Healey and local reproductive rights advocates are calling on the U.S. Supreme Court to allow continued telehealth access to the abortion drug mifepristone, which is currently in jeopardy thanks to a lawsuit brought by the state of Louisiana against the Food and Drug Administration.

The Supreme Court temporarily restored access to the abortion pill mifepristone through telehealth, mail and pharmacies, blocking an appeals court ruling.

Abortion providers have long been preparing for potential restrictions on telehealth abortion, but whiplash from court rulings challenged their plans.

At a press conference Tuesday morning, Gov. Ned Lamont reminded Connecticut residents of state resources available to access information in the wake of federal uncertainty.

Trump aims to accelerate the research, regulation, and integration of psychedelic-assisted therapies into US health care, with a particular focus on veterans and treatment-resistant mental health conditions such as posttraumatic stress disorder (PTSD) and depression.

Starting next Monday, doctors may not be able to mail people the abortion pill Mifepristone. That would increase barriers, but experts say it won't stop people's ability to get the pills in the mail.

Access to the most common abortion pill in the United States shifted twice within days, reflecting a rapidly changing legal landscape.